187 related articles for article (PubMed ID: 38361754)
1. MicroRNA (let-7b-5p)-targeted DARS2 regulates lung adenocarcinoma growth by PI3K/AKT signaling pathway.
Xu Y; Chen X
Oncol Res; 2024; 32(3):517-528. PubMed ID: 38361754
[TBL] [Abstract][Full Text] [Related]
2. Tumor-suppressive action of miR-30a-5p in lung adenocarcinoma correlates with ABL2 inhibition and PI3K/AKT pathway inactivation.
Miao Y; Liu J
Clin Transl Oncol; 2024 Feb; 26(2):398-413. PubMed ID: 37479901
[TBL] [Abstract][Full Text] [Related]
3. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
[TBL] [Abstract][Full Text] [Related]
4. DARS2 promotes the occurrence of lung adenocarcinoma via the ERK/c-Myc signaling pathway.
Fang T; Jiang J; Yu W; Li R; Tian H
Thorac Cancer; 2023 Dec; 14(36):3511-3521. PubMed ID: 37950542
[TBL] [Abstract][Full Text] [Related]
5. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
[TBL] [Abstract][Full Text] [Related]
6. MiR-485-5p Suppress the Malignant Characteristics of the Lung Adenocarcinoma via Targeting NADPH Quinone Oxidoreductase-1 to Inhibit the PI3K/Akt.
Chen Y; Wu L; Bao M
Mol Biotechnol; 2023 May; 65(5):794-806. PubMed ID: 36219369
[TBL] [Abstract][Full Text] [Related]
7. LncRNA LINC00511 promotes COL1A1-mediated proliferation and metastasis by sponging miR-126-5p/miR-218-5p in lung adenocarcinoma.
Wang Y; Mei X; Song W; Wang C; Qiu X
BMC Pulm Med; 2022 Jul; 22(1):272. PubMed ID: 35842617
[TBL] [Abstract][Full Text] [Related]
8. Centromere protein N promotes lung adenocarcinoma progression by activating PI3K/AKT signaling pathway.
Zheng Y; You H; Duan J; Chen B; Wu C; Chen P; Wang M
Genes Genomics; 2022 Sep; 44(9):1039-1049. PubMed ID: 35150399
[TBL] [Abstract][Full Text] [Related]
9. SLC39A5 promotes lung adenocarcinoma cell proliferation by activating PI3K/AKT signaling.
Liu Z; Hu Z; Cai X; Liu S
Pathol Res Pract; 2021 Aug; 224():153541. PubMed ID: 34252710
[TBL] [Abstract][Full Text] [Related]
10. High expression of DARS2 indicates poor prognosis in lung adenocarcinoma.
Jiang Y; You J; Wu C; Kang Y; Chen F; Chen L; Wu W
J Clin Lab Anal; 2022 Oct; 36(10):e24691. PubMed ID: 36085578
[TBL] [Abstract][Full Text] [Related]
11. Signal peptidase 21 suppresses cell proliferation, migration, and invasion via the PTEN-PI3K/Akt signaling pathway in lung adenocarcinoma.
Zhang N; Cao S; Sun R; Wang Y; Liu L; Wang W; Meng X
PeerJ; 2022; 10():e14206. PubMed ID: 36275477
[TBL] [Abstract][Full Text] [Related]
12. Silencing LINC01116 suppresses the development of lung adenocarcinoma via the AKT signaling pathway.
Shang B; Li Z; Li M; Jiang S; Feng Z; Cao Z; Wang H
Thorac Cancer; 2021 Jul; 12(14):2093-2103. PubMed ID: 34061456
[TBL] [Abstract][Full Text] [Related]
13. [miR-218-5p Targeting TPX2 Regulates p53 Pathway and Inhibits Malignant Progression of Lung Adenocarcinoma].
Xu J
Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):721-731. PubMed ID: 37989335
[TBL] [Abstract][Full Text] [Related]
14. The miR-4732-5p/XPR1 axis suppresses the invasion, metastasis, and epithelial-mesenchymal transition of lung adenocarcinoma
Hu Y; Bai J; Zhou D; Zhang L; Chen X; Chen L; Liu Y; Zhang B; Li H; Yin C
Mol Omics; 2022 Jun; 18(5):417-429. PubMed ID: 35388387
[TBL] [Abstract][Full Text] [Related]
15. TMEM158 functions as an oncogene and promotes lung adenocarcinoma progression through the PI3K/AKT pathway via interaction with TWIST1.
Xu T; Yin F; Shi K
Exp Cell Res; 2024 Apr; 437(1):114010. PubMed ID: 38508329
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic zinc finger protein ZNF687 accelerates lung adenocarcinoma cell proliferation and tumor progression by activating the PI3K/AKT signaling pathway.
Li M; Liu Z; Hou Z; Wang X; Shi H; Li Y; Xiao X; Tang Z; Yang J; Luo Y; Zhang M; Chen M
Thorac Cancer; 2023 May; 14(14):1223-1238. PubMed ID: 36944484
[TBL] [Abstract][Full Text] [Related]
17. FAM83B promotes the invasion of primary lung adenocarcinoma via PI3K/AKT/NF-κB pathway.
Zhang J; Wang J; Yue K; Li P; Shen W; Qiao X; Wang Y; Wu X
BMC Pulm Med; 2023 Jan; 23(1):32. PubMed ID: 36690987
[TBL] [Abstract][Full Text] [Related]
18. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway.
Zhu HE; Yin JY; Chen DX; He S; Chen H
Cell Death Dis; 2019 Nov; 10(11):854. PubMed ID: 31699997
[TBL] [Abstract][Full Text] [Related]
19. The role of HMGA2 in activating the IGFBP2 expression to promote angiogenesis and LUAD metastasis via the PI3K/AKT/VEGFA signaling pathway.
Qian S; Wang F; Liao W; Liu J
Neoplasma; 2024 Feb; 71(1):22-36. PubMed ID: 38506034
[TBL] [Abstract][Full Text] [Related]
20. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway.
Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H
Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
